by | Jul 8, 2024 | Publications
Clin Lymphoma Myeloma Leuk. 2023 Sep;23 Suppl 2:S248. doi: 10.1016/S2152-2650(23)01995-X. Epub 2023 Sep 26. ABSTRACT This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy). This article has...
by | Jul 7, 2024 | Publications
Transplant Cell Ther. 2024 Jul 4:S2666-6367(24)00490-1. doi: 10.1016/j.jtct.2024.06.030. Online ahead of print. ABSTRACT BACKGROUND: In patients with multiple myeloma, the presence of high-risk cytogenetic abnormalities is associated with worse disease control and...
by | Jul 7, 2024 | Publications
Trends Cancer. 2024 Jul 5:S2405-8033(24)00116-X. doi: 10.1016/j.trecan.2024.06.002. Online ahead of print. ABSTRACT Multiple myeloma (MM) is a hematological malignancy of bone marrow (BM) plasma cells with excessive clonal expansion and is associated with the...
by | Jul 7, 2024 | Publications
Acad Radiol. 2024 Jul 5:S1076-6332(24)00283-6. doi: 10.1016/j.acra.2024.04.048. Online ahead of print. ABSTRACT RATIONALE AND OBJECTIVES: We explored the feasibility of using total tumor apparent diffusion coefficient (ttADC) histogram parameters to predict high-risk...
by | Jul 6, 2024 | Publications
Pharmacol Res. 2024 Jul 3:107291. doi: 10.1016/j.phrs.2024.107291. Online ahead of print. ABSTRACT Fibroblast growth factors (FGFs) act as proangiogenic and mitogenic cytokines in several cancers, including multiple myeloma (MM). Indeed, corrupted FGF autocrine and...
by | Jul 6, 2024 | Publications
PET Clin. 2024 Jul 4:S1556-8598(24)00050-6. doi: 10.1016/j.cpet.2024.05.004. Online ahead of print. ABSTRACT According to international guidelines, patients with suspected myeloma should primarily undergo low-dose whole-body computed tomography (CT) for diagnostic...
